{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:50:23Z","timestamp":1790286623323,"version":"4.1.0"},"reference-count":98,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Measuring bone density by DXA is a routine means of predicting fracture risk. These 2\u2013dimensional images have limitations and may underestimate the risk of fracture due to inadequate evaluation of bone strength. The inclusion of clinical risk factors, calculating FRAX and adding TBS values all improve our ability in bone screening by DXA. However, secondary osteoporosis is not always associated with classical risk factors for bone loss. In addition, unrecognized underlying conditions may contribute to further bone loss and increased risk of low trauma fracture. Therefore, new technologies that assess bone microarchitecture, such as HR-pQCT, can improve our risk assessment for fragility fracture.<\/jats:p>","DOI":"10.3389\/fendo.2026.1768509","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T05:32:05Z","timestamp":1773034325000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Bone mineral density assessment by DXA in disease-associated osteoporosis: the limitations"],"prefix":"10.3389","volume":"17","author":[{"given":"Kamyar","family":"Asadipooya","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Molecular Medicine, Department of Medicine, University of Kentucky","place":["Lexington, KY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loren Wissner","family":"Greene","sequence":"additional","affiliation":[{"name":"Holman Division of Endocrinology, Department of Medicine, NYU Grossman School of Medicine","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jocd.2017.06.014","article-title":"Dual-energy X-ray absorptiometry","volume":"20","author":"Jain","year":"2017","journal-title":"J Clin Densitomet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3078","article-title":"Understanding bone strength is not enough","volume":"32","author":"Hernandez","year":"2017","journal-title":"J Bone Mineral Res"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.590139","article-title":"Beyond bone mineral density: A new dual X-ray absorptiometry index of bone strength to predict fragility fractures, the bone strain index","volume":"7","author":"Ulivieri","year":"2020","journal-title":"Front Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"115457","DOI":"10.1016\/j.bone.2020.115457","article-title":"The risk of hip and non-vertebral fractures in type 1 and type 2 diabetes: A systematic review and meta-analysis update","volume":"137","author":"Vilaca","year":"2020","journal-title":"Bone"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1210\/js.2019-00160","article-title":"Advanced glycation end products (AGEs), receptor for AGEs, diabetes, and bone: review of the literature","volume":"3","author":"Asadipooya","year":"2019","journal-title":"J Endocr Soc"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-006-0253-4","article-title":"Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis","volume":"18","author":"Vestergaard","year":"2007","journal-title":"Osteoporosis Int"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-3118","article-title":"TBS (trabecular bone score) and diabetes-related fracture risk","volume":"98","author":"Leslie","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocd.2020.05.009","article-title":"Bone measures by dual-energy X-ray absorptiometry and peripheral quantitative computed tomography in young women with type 1 diabetes mellitus","author":"Jiang","year":"2020","journal-title":"J Clin Densitomet"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4494","article-title":"Bone microarchitecture phenotypes identified in older adults are associated with different levels of osteoporotic fracture risk","volume":"37","author":"Whittier","year":"2022","journal-title":"J Bone Mineral Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4808","article-title":"A fracture risk assessment tool for high resolution peripheral quantitative computed tomography","volume":"38","author":"Whittier","year":"2023","journal-title":"J Bone Mineral Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-018-4532-7","article-title":"Assessment of bone quality in patients with diabetes mellitus","volume":"29","author":"Jiang","year":"2018","journal-title":"Osteoporosis Int"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-018-4650-2","article-title":"Diagnosis and management of bone fragility in diabetes: an emerging challenge","volume":"29","author":"Ferrari","year":"2018","journal-title":"Osteoporos Int"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-022-06462-3","article-title":"Management of osteoporosis in patients with chronic kidney disease","volume":"33","author":"Abdalbary","year":"2022","journal-title":"Osteoporos Int"},{"key":"B14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1093\/ndt\/gfaa192","article-title":"European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4-G5D","volume":"36","author":"Evenepoel","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad724","article-title":"Trabecular bone score as a marker of skeletal fragility across the spectrum of chronic kidney disease: A systematic review and meta-analysis","volume":"109","author":"Bioletto","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1159\/000515534","article-title":"Bone quality in CKD patients: current concepts and future directions - part I","volume":"7","author":"Asadipooya","year":"2021","journal-title":"Kidney Dis (Basel)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1159\/000515542","article-title":"Bone quality in chronic kidney disease patients: current concepts and future directions - part II","volume":"7","author":"Asadipooya","year":"2021","journal-title":"Kidney Dis (Basel)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-017-0366-z","article-title":"Bone quality in chronic kidney disease: definitions and diagnostics","volume":"15","author":"McNerny","year":"2017","journal-title":"Curr Osteoporos Rep"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-021-05822-9","article-title":"Risk of fractures in primary hyperparathyroidism: a systematic review and meta-analysis","volume":"32","author":"Ejlsmark-Svensson","year":"2021","journal-title":"Osteoporosis Int"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-2006","article-title":"Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism","volume":"94","author":"Vignali","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.01985","article-title":"The threshold of bone mineral density for vertebral fractures in female patients with primary hyperparathyroidism","volume":"153","author":"Kaji","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3461","article-title":"Prevalence and risk of vertebral fractures in primary hyperparathyroidism: A nested case-control study","volume":"33","author":"Ejlsmark-Svensson","year":"2018","journal-title":"J Bone Mineral Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-13-0305","article-title":"Bone quality, as measured by trabecular bone score, in patients with primary hyperparathyroidism","volume":"169","author":"Eller-Vainicher","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocd.2018.06.005","article-title":"Usefulness of trabecular bone score (TBS) to identify bone fragility in patients with primary hyperparathyroidism","volume":"22","author":"Mu\u00f1oz-Torres","year":"2019","journal-title":"J Clin Densitom"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocd.2021.04.001","article-title":"Trabecular bone score (TBS) in primary hyperparathyroidism (PHPT): A useful tool","volume":"24","author":"Santos","year":"2021","journal-title":"J Clin Densitom"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.23736\/S1824-4785.23.03510-0","article-title":"Bone health evaluation in primary hyperparathyroidism using dual-energy X-ray absorptiometry and trabecular bone score","volume":"67","author":"Punda","year":"2023","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"B27","doi-asserted-by":"publisher","first-page":"11795514221145840","DOI":"10.1177\/11795514221145840","article-title":"Degraded bone microarchitecture in women with PHPT-significant predictor of fracture probability","volume":"16","author":"Oprea","year":"2023","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad460","article-title":"Trabecular bone score as a more sensitive tool to evaluate bone involvement in MEN1-related primary hyperparathyroidism","volume":"109","author":"Song","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2021.08.006","article-title":"Bone analysis using trabecular bone score and dual-energy X-ray absorptiometry-based 3-dimensional modeling in postmenopausal women with primary hyperparathyroidism","volume":"28","author":"Arboiro-Pinel","year":"2022","journal-title":"Endocr Pract"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2021.04.884","article-title":"Bone quality as measured by trabecular bone score in normocalcemic primary hyperparathyroidism","volume":"27","author":"Naciu","year":"2021","journal-title":"Endocr Pract"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11020330","article-title":"Bone mineral density compared to trabecular bone score in primary hyperparathyroidism","volume":"11","author":"Jones","year":"2022","journal-title":"J Clin Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.98","article-title":"Effects on bone geometry, density, and microarchitecture in the distal radius but not the tibia in women with primary hyperparathyroidism: A case-control study using HR-pQCT","volume":"25","author":"Hansen","year":"2010","journal-title":"J Bone Mineral Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1540","article-title":"Parathyroidectomy improves bone geometry and microarchitecture in female patients with primary hyperparathyroidism: a one-year prospective controlled study using high-resolution peripheral quantitative computed tomography","volume":"27","author":"Hansen","year":"2012","journal-title":"J Bone Mineral Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1841","article-title":"Primary hyperparathyroidism is associated with abnormal cortical and trabecular microstructure and reduced bone stiffness in postmenopausal women","volume":"28","author":"Stein","year":"2013","journal-title":"J Bone Mineral Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bone.2013.03.009","article-title":"New insights into the effects of primary hyperparathyroidism on the cortical and trabecular compartments of bone","volume":"55","author":"Vu","year":"2013","journal-title":"Bone"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-019-05186-1","article-title":"Impaired geometry, volumetric density, and microstructure of cortical and trabecular bone assessed by HR-pQCT in both sporadic and MEN1-related primary hyperparathyroidism","volume":"31","author":"Wang","year":"2020","journal-title":"Osteoporos Int"},{"key":"B37","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1210\/jc.2017-01932","article-title":"Skeletal microstructure and estimated bone strength improve following parathyroidectomy in primary hyperparathyroidism","volume":"103","author":"Cusano","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab076","article-title":"Vertebral fracture assessment in postmenopausal women with postsurgical hypoparathyroidism","volume":"106","author":"Cipriani","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6823-13-1","article-title":"Increased vertebral morphometric fracture in patients with postsurgical hypoparathyroidism despite normal bone mineral density","volume":"13","author":"Mendon\u00e7a","year":"2013","journal-title":"BMC Endocr Disord"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-022-01818-2","article-title":"Vertebral fractures, trabecular bone score and their determinants in chronic hypoparathyroidism","volume":"45","author":"Saha","year":"2022","journal-title":"J Endocrinol Invest"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-3292","article-title":"Vertebral fractures and bone mineral density in patients with idiopathic hypoparathyroidism on long-term follow-up","volume":"102","author":"Chawla","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.948435","article-title":"Morphometric vertebral fracture risk in women with postsurgical hypoparathyroidism","volume":"13","author":"d\u2019Alva","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B43","doi-asserted-by":"publisher","first-page":"117274","DOI":"10.1016\/j.bone.2024.117274","article-title":"Predictors of lumbar spine trabecular bone score in women with postsurgical hypoparathyroidism","volume":"190","author":"Carvalho","year":"2025","journal-title":"Bone"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-023-03495-4","article-title":"Chronic hypoparathyroidism is associated with increased cortical bone density evaluated using high-resolution peripheral quantitative computed tomography","volume":"82","author":"Santa Rosa","year":"2023","journal-title":"Endocrine"},{"key":"B45","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s40618-023-02177-2","article-title":"Features of patients and fracture risk in hypoparathyroidism; a single center study","volume":"47","author":"Slutzky-Shraga","year":"2024","journal-title":"J Endocrinol Invest"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4871","article-title":"Risk of fractures in thyroid cancer patients with postoperative hypoparathyroidism: A nationwide cohort study in korea","volume":"38","author":"Ahn","year":"2023","journal-title":"J Bone Mineral Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2273","article-title":"Postsurgical hypoparathyroidism--risk of fractures, psychiatric diseases, cancer, cataract, and infections","volume":"29","author":"Underbjerg","year":"2014","journal-title":"J Bone Mineral Res"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-021-05966-8","article-title":"Fracture risk in hypoparathyroidism: a systematic review and meta-analysis","volume":"32","author":"Pal","year":"2021","journal-title":"Osteoporos Int"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-013-2207-2","article-title":"Attenuation of postmenopausal bone loss in patients with transient hypoparathyroidism after total thyroidectomy","volume":"37","author":"Takamura","year":"2013","journal-title":"World J Surg"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-016-3750-0","article-title":"Bone imaging in hypoparathyroidism","volume":"28","author":"Silva","year":"2017","journal-title":"Osteoporos Int"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-019-05177-2","article-title":"PTH and bone material strength in hypoparathyroidism as measured by impact microindentation","volume":"31","author":"Starr","year":"2020","journal-title":"Osteoporos Int"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2020.0084","article-title":"Consequences of hyperthyroidism and its treatment for bone microarchitecture assessed by high-resolution peripheral quantitative computed tomography","volume":"31","author":"Nicolaisen","year":"2021","journal-title":"Thyroid"},{"key":"B53","article-title":"Assessment of bone metabolism in premenopausal females with hyperthyroidism and hypothyroidism","volume":"64","author":"Tuchendler","year":"2013","journal-title":"Endokrynol Pol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9041034","article-title":"Thyroid hormone diseases and osteoporosis","volume":"9","author":"Delitala","year":"2020","journal-title":"J Clin Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-015-3221-z","article-title":"Relationship between subclinical thyroid dysfunction and the risk of fracture: a meta-analysis of prospective cohort studies","volume":"27","author":"Yan","year":"2016","journal-title":"Osteoporosis Int"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.7326\/M14-0125","article-title":"Subclinical thyroid dysfunction and the risk for fractures: a systematic review and meta-analysis","volume":"161","author":"Wirth","year":"2014","journal-title":"Ann Internal Med"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-019-02110-9","article-title":"Association of subclinical thyroid dysfunction with bone mineral density and fracture: a meta-analysis of prospective cohort studies","volume":"67","author":"Zhu","year":"2020","journal-title":"Endocrine"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.5161","article-title":"Subclinical thyroid dysfunction and fracture risk: a meta-analysis","volume":"313","author":"Blum","year":"2015","journal-title":"Jama"},{"key":"B59","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/joim.12688","article-title":"Association between subclinical thyroid dysfunction and change in bone mineral density in prospective cohorts","volume":"283","author":"Segna","year":"2018","journal-title":"J Internal Med"},{"key":"B60","doi-asserted-by":"publisher","first-page":"796871","DOI":"10.1155\/2015\/796871","article-title":"Bone indices in thyroidectomized patients on long-term substitution therapy with levothyroxine assessed by DXA and HR-pQCT","volume":"2015","author":"Moser","year":"2015","journal-title":"J Thyroid Res"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-019-05205-1","article-title":"Subclinical thyroid dysfunction, bone mineral density, and osteoporosis in a middle-aged Korean population","volume":"31","author":"Lee","year":"2020","journal-title":"Osteoporosis Int"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1210\/er.2018-00097","article-title":"Glucocorticoids and bone: consequences of endogenous and exogenous excess and replacement therapy","volume":"39","author":"Hardy","year":"2018","journal-title":"Endocrine Rev"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1002\/art.40137","article-title":"2017 american college of rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"69","author":"Buckley","year":"2017","journal-title":"Arthritis Rheumatol (Hoboken NJ)"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-019-04871-5","article-title":"The effects of cortisol and adrenal androgen on bone mass in Asians with and without subclinical hypercortisolism","volume":"30","author":"Ahn","year":"2019","journal-title":"Osteoporosis Int"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-014-2784-4","article-title":"Cortisol and the muscle-bone axis","volume":"25","author":"Molfino","year":"2014","journal-title":"Osteoporosis Int"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa263","article-title":"Bone evaluation by high-resolution peripheral quantitative computed tomography in patients with adrenal incidentaloma","volume":"105","author":"Moraes","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-013-2588-y","article-title":"Treatment of skeletal impairment in patients with endogenous hypercortisolism: when and how","volume":"25","author":"Scillitani","year":"2014","journal-title":"Osteoporosis Int"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa363","article-title":"Treatment of acromegalic osteopathy in real-life clinical practice: the BAAC (Bone active drugs in acromegaly) study","volume":"105","author":"Mazziotti","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2695","article-title":"Progression of vertebral fractures despite long-term biochemical control of acromegaly: a prospective follow-up study","volume":"98","author":"Claessen","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-015-3344-2","article-title":"Trabecular bone score as a skeletal fragility index in acromegaly patients","volume":"27","author":"Hong","year":"2016","journal-title":"Osteoporosis Int"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-4073","article-title":"Acromegaly has a negative influence on trabecular bone, but not on cortical bone, as assessed by high-resolution peripheral quantitative computed tomography","volume":"98","author":"Madeira","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-3921","article-title":"Effects of recombinant human growth hormone therapy on bone mineral density in adults with growth hormone deficiency: a meta-analysis","volume":"99","author":"Barake","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-016-0716-3","article-title":"Fractures in pituitary adenoma patients from the Dutch National Registry of Growth Hormone Treatment in Adults","volume":"19","author":"van Varsseveld","year":"2016","journal-title":"Pituitary"},{"key":"B74","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s12020-017-1440-0","article-title":"Effects of growth hormone therapy on bone density and fracture risk in age-related osteoporosis in the absence of growth hormone deficiency: a systematic review and meta-analysis","volume":"59","author":"Barake","year":"2018","journal-title":"Endocrine"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-18-0711","article-title":"Bone microarchitecture and volumetric bone density impairment in young male adults with childhood-onset growth hormone deficiency","volume":"180","author":"Yang","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab149","article-title":"Effect of Testosterone treatment on bone microarchitecture and bone mineral density in men: a two-year RCT","volume":"106","author":"Ng Tang Fui","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10030530","article-title":"Testosterone and bone health in men: A narrative review","volume":"10","author":"Shigehara","year":"2021","journal-title":"J Clin Med"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2013.10.070","article-title":"Bone mineral density and response to treatment in men younger than 50 years with testosterone deficiency and sexual dysfunction or infertility","volume":"191","author":"Kacker","year":"2014","journal-title":"J Urol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-0183","article-title":"Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer","volume":"90","author":"Greenspan","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-013-2343-4","article-title":"Changes in bone mineral density in men starting androgen deprivation therapy and the protective role of vitamin D","volume":"24","author":"Alibhai","year":"2013","journal-title":"Osteoporos Int"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-018-4722-3","article-title":"Patients with prostate cancer and androgen deprivation therapy have increased risk of fractures-a study from the fractures and fall injuries in the elderly cohort (FRAILCO)","volume":"30","author":"Wallander","year":"2019","journal-title":"Osteoporos Int"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-026-01077-9","article-title":"Risk of bone fractures in patients with prostate cancer treated with maximal androgen blockade therapy: a systematic literature review and meta-analysis","author":"Saporita","year":"2026","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"B83","doi-asserted-by":"publisher","first-page":"100713","DOI":"10.1016\/j.jbo.2025.100713","article-title":"Alteration of bone architecture following androgen deprivation therapy in patients with prostate cancer using 3D-modeling from hip DXA","volume":"55","author":"Park","year":"2025","journal-title":"J Bone Oncol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"117643","DOI":"10.1016\/j.bone.2025.117643","article-title":"Bone microarchitecture and strength in men with prostate cancer with and without prevalent vertebral fractures at the initiation of androgen deprivation therapy","volume":"201","author":"van Oostwaard","year":"2025","journal-title":"Bone"},{"key":"B85","doi-asserted-by":"publisher","first-page":"100611","DOI":"10.1016\/j.jbo.2024.100611","article-title":"The impact of androgen deprivation therapy on bone microarchitecture in men with prostate cancer: A longitudinal observational study (The ANTELOPE Study)","volume":"47","author":"Handforth","year":"2024","journal-title":"J Bone Oncol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3746","article-title":"Relationship between sex steroids and deterioration of bone microarchitecture in older men: the prospective STRAMBO study","volume":"34","author":"Piot","year":"2019","journal-title":"J Bone Mineral Res"},{"key":"B87","doi-asserted-by":"publisher","first-page":"108708","DOI":"10.1016\/j.maturitas.2025.108708","article-title":"Changes in femoral 3D-DXA cortical and trabecular indices in postmenopausal women with early breast cancer treated with aromatase inhibitors: a prospective study of the B-ABLE cohort","volume":"201","author":"Garcia-Giralt","year":"2025","journal-title":"Maturitas"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-024-01560-0","article-title":"Aromatase inhibitors, bone microstructure, and estimated bone strength in postmenopausal women with breast cancer: a 5-year prospective study","volume":"43","author":"Kuba","year":"2025","journal-title":"J Bone Miner Metab"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.20945\/2359-3997000000385","article-title":"Use of aromatase inhibitors in patients with breast cancer is associated with deterioration of bone microarchitecture and density","volume":"65","author":"Nunes","year":"2021","journal-title":"Arch Endocrinol Metab"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21103538","article-title":"Hematological diseases and osteoporosis","volume":"21","author":"Gaudio","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57020094","article-title":"Quantitative imaging and radiomics in multiple myeloma: A potential opportunity","volume":"57","author":"Tagliafico","year":"2021","journal-title":"Med (Kaunas Lithuania)"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.22912","article-title":"Quantitative computed tomography is unreliable for measurement of bone mineral density in inadequately chelated adolescent patients with \u03b2-thalassemia major: a case-control study","volume":"56","author":"Bansal","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"B93","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-030-27820-5_8","volume-title":"Systemic Mastocytosis and Bone-Related Events","author":"Asadipooya","year":"2020"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-025-07726-4","article-title":"Management of skeletal-related events and fracture prevention in systemic mastocytosis","author":"Lunn","year":"2025","journal-title":"Osteoporos Int"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket007","article-title":"Friend or foe: high bone mineral density on routine bone density scanning, a review of causes and management","volume":"52","author":"Gregson","year":"2013","journal-title":"Rheumatol (Oxford)"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-007-0437-6","article-title":"Effects of treatment with fluoride on bone mineral density and fracture risk--a meta-analysis","volume":"19","author":"Vestergaard","year":"2008","journal-title":"Osteoporos Int"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.060724","article-title":"Effects of strontium on bone strength, density, volume, and microarchitecture in laying hens","volume":"21","author":"Shahnazari","year":"2006","journal-title":"J Bone Mineral Res"},{"key":"B98","doi-asserted-by":"publisher","first-page":"116013","DOI":"10.1016\/j.bone.2021.116013","article-title":"Which skeletal imaging modality is best for assessing bone health in children and young adults compared to DXA? A systematic review and meta-analysis","volume":"150","author":"Shalof","year":"2021","journal-title":"Bone"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1768509\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T05:32:06Z","timestamp":1773034326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1768509\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":98,"alternative-id":["10.3389\/fendo.2026.1768509"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1768509","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"article-number":"1768509"}}